Qube Research & Technologies (QRT)
VERA icon

Qube Research & Technologies (QRT)’s Vera Therapeutics VERA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.5M Buy
1,083,179
+541,380
+100% +$20.2M 0.04% 520
2026
Q1 		$21.8M Buy
541,799
+163,744
+43% +$7.05M 0.02% 835
2025
Q4 		$19.1M Sell
378,055
-83,355
-18% -$2.96M 0.02% 938
2025
Q3 		$13.4M Buy
461,410
+149,468
+48% +$3.46M 0.01% 1134
2025
Q2 		$7.35M Sell
311,942
-32,681
-9% -$735K 0.01% 1476
2025
Q1 		$8.28M Buy
344,623
+174,137
+102% +$5.6M 0.01% 1249
2024
Q4 		$7.21M Buy
170,486
+157,110
+1,175% +$6.96M 0.01% 1298
2024
Q3 		$591K Buy
+13,376
New +$508K ﹤0.01% 2209
2024
Q2 		– Sell
-20,356
Closed -$878K – 4768
2024
Q1 		$878K Buy
+20,356
New +$725K ﹤0.01% 2225

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Qube Research & Technologies (QRT)'s VERA Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Vera Therapeutics (VERA) stake by 100% in Q2 2026, buying an estimated $20.2M and bringing the position to 1,083,179 shares worth $46.5M. The position accounts for 0.04% of the portfolio, ranked #520.

Qube Research & Technologies (QRT) first reported a position in VERA in Q1 2024 and has held it in 9 quarters since. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Qube Research & Technologies (QRT) held 1,083,179 shares of Vera Therapeutics worth $46.5M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 541,380 Vera Therapeutics shares in Q2 2026, an estimated $20.2M.
  • Vera Therapeutics made up 0.04% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #520 holding.
  • Qube Research & Technologies (QRT) first reported a position in Vera Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • 220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.